ISOO Session Highlights
We look forward to an exciting program this year in France. Please see below for the ISOO session highlights.
For the full program, click here.
Thursday, June 27, 2024
ISOO Session 1: Diagnostic and Management of Emerging Oral Toxicities
Chaired by Dr Eduardo Fregnani (Brazil)
- Dr Ourania Nicolatou-Galitis (Greece): Diagnosis of Emerging Oral Toxicities
- Dr Sharon Elad (USA): Management of Emerging Oral Toxicities
Tomohiro Shibata
JAPAN
Tomohiro Shibata
JAPAN
Tomohiro Shibata
JAPAN
Tomohiro Shibata
JAPAN
Friday, June 28, 2024
ISOO Session 2: Enhancing Home-Based Supportive Care for Oral Toxicities in Cancer Patients
Chaired by Dr Sophie Beaumont (Australia)
- Dr Ron Sabar (Israel): A Nation-Wide Home Base Palliative Care Service – The Israeli Model
- Dr Cristina Kline-Quiroz (USA): Utilizing Innovative Technologies for Managing Long-Term Head and Neck Complications in a Home Setting
Tomohiro Shibata
JAPAN
Tomohiro Shibata
JAPAN
Tomohiro Shibata
JAPAN
Tomohiro Shibata
JAPAN
Tomohiro Shibata
JAPAN
Saturday, June 29, 2024
ISOO Session 3: Exploring Challenges and Resilience in Head and Neck Cancer Survivors (Joint Session with EORTC Quality of Life Group)
Chaired by Dr Noam Yarom (Israel), Dr Anne Brédart (France)
- Prof Susanne Singer (Germany): Unraveling Head and Neck Cancer Survivors’ Mental Resilience and Quality of Life
- Prof Bente Brokstad Herlofson (Norway): Unmasking the Lingering Shadows: Late Toxicities in Head and Neck Cancer
Tomohiro Shibata
JAPAN
Tomohiro Shibata
JAPAN
Tomohiro Shibata
JAPAN
Sessions Supported by the MASCC Oral Care Study Group
Management of Graft Versus Host Disease - State of the Art and Recent Advances
Chaired by Prof Sharon Elad (USA), Assoc Prof Nathaniel Treister (USA)
- Assoc Prof David Dean (USA): Oral Chronic Graft versus Host Disease – Current and Future Perspectives
- Prof Nicole Blijlevens (The Netherlands): Graft Versus Host Disease – Innovative Therapies
Tomohiro Shibata
JAPAN
Tomohiro Shibata
JAPAN
Tomohiro Shibata
JAPAN
MASCC/ISOO Guidelines and Clinical Practice Statements in the Making
Chaired by Prof Fred Ashbury (Canada), Dr Niharika Dixit (USA)
- Dr Sharon Elad (USA): Clinical Practice Statements – Insights From the Oral Care Study Group Experience
- Dr Fabienne Thomas (France): The MASCC DPYD Testing Guidelines –Rationale and Ongoing Work
Tomohiro Shibata
JAPAN
Tomohiro Shibata
JAPAN
Tomohiro Shibata
JAPAN
Oral and Cutaneous Complications of Immunotherapy: Advances in Treatment and Prediction
Chaired by Prof Sharon Elad (USA), Dr Satoshi Hirakawa (Japan)
- Prof Joel Epstein (USA): Oral Complications of Immunotherapy – Current and Future Perspectives
- Assoc Prof Yoshinobu Kano (Japan): A Potential Role of Artificial Intelligence in Mucosal and/or Cutaneous Adverse Events by Immune Checkpoint Inhibitors for Cancer Patients
Tomohiro Shibata
JAPAN
Tomohiro Shibata
JAPAN
Tomohiro Shibata
JAPAN
